Huadong Medicine Co., Ltd (000963.SZ) announced earnings for its first quarter that Increased, from last year
The company's bottom line totaled RMB1.002 billion, or RMB0.5715 per share. This compares with RMB0.914 billion, or RMB0.5213 per share, last year.
The company's revenue for the period rose 4.2% to RMB11.183 billion from RMB10.735 billion last year.
Huadong Medicine Co., Ltd earnings at a glance (GAAP) :
-Earnings: RMB1.002 Bln. vs. RMB0.914 Bln. last year.-EPS: RMB0.5715 vs. RMB0.5213 last year.-Revenue: RMB11.183 Bln vs. RMB10.735 Bln last year.
For comments and feedback contact: editorial@rttnews.com
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.